Document Type

Poster

Publication Date

3-22-2024

Abstract

Hyperhomocysteinemia, or elevated levels of blood homocysteine, is a metabolic condition caused by dietary deficiency of folate, vitamin B12, and vitamin B6 and has been implicated in neurological disorders including ischemic stroke and dementia. We show that following ischemic stroke, hyperhomocysteinemia exacerbates brain damage by triggering a neuro-inflammatory response via a unique intracellular pathway involving GluN2A-NMDA receptors. As such, inhibiting this pathway could yield potential drug targets to mitigate brain damage in hyperhomocysteinemic stroke patients.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.